UniSuper Management Pty Ltd lowered its stake in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 20.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,000 shares of the company’s stock after selling 3,300 shares during the quarter. UniSuper Management Pty Ltd’s holdings in Avantor were worth $274,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the company. Louisiana State Employees Retirement System boosted its holdings in Avantor by 0.3% during the fourth quarter. Louisiana State Employees Retirement System now owns 188,900 shares of the company’s stock worth $3,980,000 after purchasing an additional 500 shares during the last quarter. Hantz Financial Services Inc. lifted its position in shares of Avantor by 2.1% during the 3rd quarter. Hantz Financial Services Inc. now owns 24,900 shares of the company’s stock worth $644,000 after buying an additional 503 shares in the last quarter. Blue Trust Inc. lifted its position in shares of Avantor by 6.9% during the 4th quarter. Blue Trust Inc. now owns 8,069 shares of the company’s stock worth $170,000 after buying an additional 522 shares in the last quarter. Pacer Advisors Inc. grew its holdings in shares of Avantor by 0.5% in the fourth quarter. Pacer Advisors Inc. now owns 99,825 shares of the company’s stock valued at $2,103,000 after acquiring an additional 542 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB increased its position in shares of Avantor by 99.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after acquiring an additional 625 shares during the last quarter. Institutional investors own 95.08% of the company’s stock.
Avantor Trading Up 0.3 %
NYSE:AVTR opened at $16.24 on Tuesday. The company has a market cap of $11.05 billion, a P/E ratio of 15.61, a P/E/G ratio of 1.55 and a beta of 1.30. Avantor, Inc. has a 1 year low of $15.37 and a 1 year high of $28.00. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70. The stock’s fifty day moving average price is $18.28 and its two-hundred day moving average price is $21.28.
Analysts Set New Price Targets
Several research firms have weighed in on AVTR. UBS Group reissued a “neutral” rating and issued a $25.00 price objective (down previously from $29.00) on shares of Avantor in a research report on Friday, January 17th. Wells Fargo & Company cut their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a report on Monday, February 10th. Citigroup decreased their price objective on shares of Avantor from $22.00 to $18.00 and set a “neutral” rating for the company in a report on Tuesday, March 4th. Cowen reiterated a “buy” rating on shares of Avantor in a research note on Tuesday, March 18th. Finally, Stifel Nicolaus decreased their price target on shares of Avantor from $28.00 to $26.00 and set a “buy” rating for the company in a research note on Monday, February 10th. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $25.50.
View Our Latest Stock Report on AVTR
Insider Activity
In other Avantor news, EVP James Bramwell sold 3,758 shares of the firm’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the sale, the executive vice president now owns 87,379 shares in the company, valued at $1,531,753.87. This trade represents a 4.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Steven W. Eck sold 4,907 shares of the business’s stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the sale, the chief accounting officer now owns 40,604 shares of the company’s stock, valued at $711,788.12. The trade was a 10.78 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.50% of the company’s stock.
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Stories
- Five stocks we like better than Avantor
- What Are Treasury Bonds?
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- What is the Dogs of the Dow Strategy? Overview and Examples
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- What is a Death Cross in Stocks?
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.